Apeloa Pharmaceutical Co.,Ltd
000739
Classement en actions
#4291
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Prix de l'action
$3.13
Capitalisation boursière
$3.62B
Changement (1 jour)
-1.42%
Changement (1 an)
46.59%
Pays
CN
Échange Apeloa Pharmaceutical Co.,Ltd (000739)
Catégorie
Healthcare
Ratio P/B pour Apeloa Pharmaceutical Co.,Ltd (000739)
Ratio P/B au October 2026 TTM : 3.59
Selon les derniers rapports financiers et le cours de l'action de Apeloa Pharmaceutical Co.,Ltd, le ratio cours/valeur comptable actuel (TTM) est 3.59. À la fin de 2024, le ratio P/B était de 2.79.
Historique du ratio P/B pour Apeloa Pharmaceutical Co.,Ltd de 2000 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 3.59 | 21.27% |
| 2025 | 2.96 | 5.96% |
| 2024 | 2.79 | -4.02% |
| 2023 | 2.91 | -36.30% |
| 2022 | 4.57 | -44.09% |
| 2021 | 8.17 | 30.79% |
| 2020 | 6.25 | 54.03% |
| 2019 | 4.06 | 55.35% |
| 2018 | 2.61 | 6.58% |
| 2017 | 2.45 | -25.52% |
| 2016 | 3.29 | -15.47% |
| 2015 | 3.89 | 8.52% |
| 2014 | 3.59 | 61.94% |
| 2013 | 2.21 | 84.56% |
| 2012 | 1.20 | -71.82% |
| 2011 | 4.26 | 43.16% |
| 2010 | 2.97 | -10.68% |
| 2009 | 3.33 | 131.56% |
| 2008 | 1.44 | -62.40% |
| 2007 | 3.82 | 20.96% |
| 2006 | 3.16 | 103.63% |
| 2005 | 1.55 | -23.64% |
| 2004 | 2.03 | -11.01% |
| 2003 | 2.29 | -41.50% |
| 2002 | 3.91 | -43.69% |
| 2001 | 6.94 | 17.81% |
| 2000 | 5.89 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 1.3124 | -63.44% |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 40.43% |
IN
|
